biztrac. BETA
COMPANY REGISTER PROFILE
979996233 ORG. NO. 2025 ACCOUNTS 9 SECTIONS
Active UPDATED 03.10.2026
Wholesale of pharmaceutical and medical goods

ORIFARM AS

Org. no. 979996233 Limited company (AS) Oslo Incorporated 1998 Active
Ownership graph ↗
Revenue 2025 NOK 250.3m
Operating profit NOK 3.1m
Equity NOK 4.3m
Incorporated 1998
Employees 9
Share capital NOK 500,000

ORIFARM AS is registered as a limited company in Oslo, Oslo with organisation number 979996233. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 1998 and has 9 registered employees. Registered share capital is NOK 500,000, divided into 500 shares. The company's stated purpose is: “Import og eksport samt handel med legemidler og øvrige helsepleieprodukter.”. The most recent filed accounts, for the 2025 financial year, show NOK 250.3m in revenue and NOK 3.1m in operating profit.

Key figures · 2025

Revenue
NOK 250.3m
▼ −32 %
Operating profit
NOK 3.1m
▼ −33 %
Equity
NOK 4.3m
▼ −67 %
Est. value
NOK 15.2m

Financial health · 2025

Liquidity
0.90
Weak
Current assets ÷ current liabilities
Profitability
9.0%
Satisfactory
Return on total assets
Solidity
9.4%
Weak
Equity as a share of total capital

Who owns ORIFARM AS?

ORFARM HOLDING AS DK
ORIFARM AS
NOK 250.3m rev. · NOK 3.1m profit

ORIFARM AS has 1 registered shareholder:

  • ORFARM HOLDING AS 100.0%
All shareholders and roles →

Group structure

ORIFARM AS er morselskap for 1 datterselskap:

Frequently asked questions about ORIFARM AS

Who owns ORIFARM AS?

ORFARM HOLDING AS is the largest registered owner, with 100.0%.

What is the revenue of ORIFARM AS?

ORIFARM AS had revenue of NOK 250.3m in 2025.

Who is the general manager of ORIFARM AS?

Sverre Haugen is registered as general manager of ORIFARM AS.

Where is ORIFARM AS based?

ORIFARM AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.